EVLV director sells 80,745 shares after option exercise at $0.24
Evolv Technologies Holdings (EVLV) reported a director’s Form 4 for transactions on 10/15/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Evolv Technologies Holdings (EVLV) reported a director’s Form 4 for transactions on 10/15/2025. The insider exercised 80,745 stock options at $0.24 and then sold 80,745 Class A shares at a $8.26 weighted average, with sales executed between $8.03 and $8.54, pursuant to a Rule 10b5-1 plan entered on June 12, 2025.
Following the transactions, the insider beneficially owned 2,083,961 shares directly and 151,135 shares indirectly (held by Family Horizon Trust), and held 1,542,974 derivative securities (stock options).
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 80,745 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 80,745 | $0.24 | $19K |
| Sale | Class A Common Stock | 80,745 | $8.26 | $667K |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (3)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.03 to $8.54. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did EVLV’s insider do on 10/15/2025?
Was the EVLV sale under a Rule 10b5-1 plan?
What derivative holdings remain after the EVLV transactions?
What do the transaction codes mean in this EVLV Form 4?
What role does the reporting person have at EVLV?
AI-generated analysis. How Rhea-AI works. Not financial advice.